SASL Swiss Cirrhosis Cohort
NCT06092385
Summary
This is a national prospective long-term multicentre observational cohort study following patients with cirrhosis in order to systematically and longitudinally record epidemiological, clinical, histological, psychosocial and patient-reported data and biobank biological material from patients with cirrhosis. The central element of all scientific operation and productivity in the Swiss Cirrhosis Cohort Study (SSCiCoS) is the so-called "nested project" (NP). Based on the evolving large pool of data and biological samples, SSCiCoS investigators use the data pool in order to investigate specific hypotheses and questions.
Eligibility
Inclusion Criteria: * A) Patients with chronic liver disease and histologically proven cirrhosis * B) Control subjects with no signs of cirrhosis Exclusion Criteria: * Age \<18 years * patients who developed hepatocellular carcinoma (HCC) and/or cholangiocellular carcinoma (CCC)
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06092385